IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Biocon Biologics Limited opposition analysis
COMPANY ANALYSIS
Latest oppositions filed by Biocon Biologics Limited
Patent Number:
EP3883606
Title:
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Apr 8, 2024
Latest oppositions filed by Biocon Biologics Limited
Patent Number
Title
Applicant
Opposition Date
EP3883606
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody
JANSSEN BIOTECH, INC.
Apr 8, 2024
Competitors of Biocon Biologics Limited
JANSSEN BIOTECH, INC.
Want to track Biocon Biologics Limited?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch